New research: A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy: We describe the first case report of a patient with COVID19 infection and metastatic breast cancer, while on systemic… https://t.c
RT @KFSHRC_Research: A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy https:/…
RT @KFSHRC_Research: A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy https:/…
A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy https://t.co/K3GyaC8J2j https://t.co/4rpVYmUdkH
A protracted course of COVID19 infection in a metastatic breast cancer patient during CDK4/6 inhibitor therapy https://t.co/J15JNvSqUN